466 related articles for article (PubMed ID: 33608690)
1. Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer.
Ragoonanan D; Khazal SJ; Abdel-Azim H; McCall D; Cuglievan B; Tambaro FP; Ahmad AH; Rowan CM; Gutierrez C; Schadler K; Li S; Di Nardo M; Chi L; Gulbis AM; Shoberu B; Mireles ME; McArthur J; Kapoor N; Miller J; Fitzgerald JC; Tewari P; Petropoulos D; Gill JB; Duncan CN; Lehmann LE; Hingorani S; Angelo JR; Swinford RD; Steiner ME; Hernandez Tejada FN; Martin PL; Auletta J; Choi SW; Bajwa R; Dailey Garnes N; Kebriaei P; Rezvani K; Wierda WG; Neelapu SS; Shpall EJ; Corbacioglu S; Mahadeo KM
Nat Rev Clin Oncol; 2021 Jul; 18(7):435-453. PubMed ID: 33608690
[TBL] [Abstract][Full Text] [Related]
2. Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy.
Mahadeo KM; Khazal SJ; Abdel-Azim H; Fitzgerald JC; Taraseviciute A; Bollard CM; Tewari P; Duncan C; Traube C; McCall D; Steiner ME; Cheifetz IM; Lehmann LE; Mejia R; Slopis JM; Bajwa R; Kebriaei P; Martin PL; Moffet J; McArthur J; Petropoulos D; O'Hanlon Curry J; Featherston S; Foglesong J; Shoberu B; Gulbis A; Mireles ME; Hafemeister L; Nguyen C; Kapoor N; Rezvani K; Neelapu SS; Shpall EJ;
Nat Rev Clin Oncol; 2019 Jan; 16(1):45-63. PubMed ID: 30082906
[TBL] [Abstract][Full Text] [Related]
3. Extracorporeal membrane oxygenation in children receiving haematopoietic cell transplantation and immune effector cell therapy: an international and multidisciplinary consensus statement.
Di Nardo M; Ahmad AH; Merli P; Zinter MS; Lehman LE; Rowan CM; Steiner ME; Hingorani S; Angelo JR; Abdel-Azim H; Khazal SJ; Shoberu B; McArthur J; Bajwa R; Ghafoor S; Shah SH; Sandhu H; Moody K; Brown BD; Mireles ME; Steppan D; Olson T; Raman L; Bridges B; Duncan CN; Choi SW; Swinford R; Paden M; Fortenberry JD; Peek G; Tissieres P; De Luca D; Locatelli F; Corbacioglu S; Kneyber M; Franceschini A; Nadel S; Kumpf M; Loreti A; Wösten-Van Asperen R; Gawronski O; Brierley J; MacLaren G; Mahadeo KM
Lancet Child Adolesc Health; 2022 Feb; 6(2):116-128. PubMed ID: 34895512
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement.
Mahadeo KM; Bajwa R; Abdel-Azim H; Lehmann LE; Duncan C; Zantek N; Vittorio J; Angelo J; McArthur J; Schadler K; Chan S; Tewari P; Khazal S; Auletta JJ; Choi SW; Shoberu B; Kalwak K; Harden A; Kebriaei P; Abe JI; Li S; Moffet JR; Abraham S; Tambaro FP; Kleinschmidt K; Richardson PG; Corbacioglu S;
Lancet Haematol; 2020 Jan; 7(1):e61-e72. PubMed ID: 31818728
[TBL] [Abstract][Full Text] [Related]
5. Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Pearson AD; Rossig C; Mackall C; Shah NN; Baruchel A; Reaman G; Ricafort R; Heenen D; Bassan A; Berntgen M; Bird N; Bleickardt E; Bouchkouj N; Bross P; Brownstein C; Cohen SB; de Rojas T; Ehrlich L; Fox E; Gottschalk S; Hanssens L; Hawkins DS; Horak ID; Taylor DH; Johnson C; Karres D; Ligas F; Ludwinski D; Mamonkin M; Marshall L; Masouleh BK; Matloub Y; Maude S; McDonough J; Minard-Colin V; Norga K; Nysom K; Pappo A; Pearce L; Pieters R; Pule M; Quintás-Cardama A; Richardson N; Schüßler-Lenz M; Scobie N; Sersch MA; Smith MA; Sterba J; Tasian SK; Weigel B; Weiner SL; Zwaan CM; Lesa G; Vassal G
Eur J Cancer; 2022 Jan; 160():112-133. PubMed ID: 34840026
[TBL] [Abstract][Full Text] [Related]
6. Advances in Supportive Care for Acute Lymphoblastic Leukemia.
Cook J; Litzow M
Curr Hematol Malig Rep; 2020 Aug; 15(4):276-293. PubMed ID: 32607955
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy: enhancing the efficacy of this promising therapeutic in multiple cancers.
Inthagard J; Edwards J; Roseweir AK
Clin Sci (Lond); 2019 Jan; 133(2):181-193. PubMed ID: 30659159
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic Cell Transplantation for Philadelphia Chromosome Negative Adult Acute Lymphoblastic Leukemia in the Modern Era of Immune Therapy.
Yurkiewicz I; Craig J; Muffly L
Curr Hematol Malig Rep; 2020 Jun; 15(3):187-193. PubMed ID: 32358681
[TBL] [Abstract][Full Text] [Related]
9. Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance.
Martins F; Sofiya L; Sykiotis GP; Lamine F; Maillard M; Fraga M; Shabafrouz K; Ribi C; Cairoli A; Guex-Crosier Y; Kuntzer T; Michielin O; Peters S; Coukos G; Spertini F; Thompson JA; Obeid M
Nat Rev Clin Oncol; 2019 Sep; 16(9):563-580. PubMed ID: 31092901
[TBL] [Abstract][Full Text] [Related]
10. Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-related adverse events: pulmonary toxicity.
Shannon VR; Anderson R; Blidner A; Choi J; Cooksley T; Dougan M; Glezerman I; Ginex P; Girotra M; Gupta D; Johnson DB; Suarez-Almazor ME; Rapoport BL
Support Care Cancer; 2020 Dec; 28(12):6145-6157. PubMed ID: 32880733
[TBL] [Abstract][Full Text] [Related]
11. Current developments in immunotherapy in the treatment of multiple myeloma.
Köhler M; Greil C; Hudecek M; Lonial S; Raje N; Wäsch R; Engelhardt M
Cancer; 2018 May; 124(10):2075-2085. PubMed ID: 29409124
[TBL] [Abstract][Full Text] [Related]
12. [Toxicities of immune checkpoint inhibitors and their management].
Kostine M; Marabelle A; Schaeverbeke T; Kfoury M
Med Sci (Paris); 2019 Dec; 35(12):949-956. PubMed ID: 31903899
[TBL] [Abstract][Full Text] [Related]
13. ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells.
Lee DW; Santomasso BD; Locke FL; Ghobadi A; Turtle CJ; Brudno JN; Maus MV; Park JH; Mead E; Pavletic S; Go WY; Eldjerou L; Gardner RA; Frey N; Curran KJ; Peggs K; Pasquini M; DiPersio JF; van den Brink MRM; Komanduri KV; Grupp SA; Neelapu SS
Biol Blood Marrow Transplant; 2019 Apr; 25(4):625-638. PubMed ID: 30592986
[TBL] [Abstract][Full Text] [Related]
14. Critical Care Management of Toxicities Associated With Targeted Agents and Immunotherapies for Cancer.
Gutierrez C; McEvoy C; Munshi L; Stephens RS; Detsky ME; Nates JL; Pastores SM
Crit Care Med; 2020 Jan; 48(1):10-21. PubMed ID: 31725440
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy-Related Acute Kidney Injury.
Manohar S; Jhaveri KD; Perazella MA
Adv Chronic Kidney Dis; 2021 Sep; 28(5):429-437.e1. PubMed ID: 35190109
[TBL] [Abstract][Full Text] [Related]
16. A review of cancer immunotherapy toxicity.
Kennedy LB; Salama AKS
CA Cancer J Clin; 2020 Mar; 70(2):86-104. PubMed ID: 31944278
[TBL] [Abstract][Full Text] [Related]
17. Candidacy for Extracorporeal Life Support in Children After Hematopoietic Cell Transplantation: A Position Paper From the Pediatric Acute Lung Injury and Sepsis Investigators Network's Hematopoietic Cell Transplant and Cancer Immunotherapy Subgroup.
Zinter MS; McArthur J; Duncan C; Adams R; Kreml E; Dalton H; Abdel-Azim H; Rowan CM; Gertz SJ; Mahadeo KM; Randolph AG; Rajapreyar P; Steiner ME; Lehmann L;
Pediatr Crit Care Med; 2022 Mar; 23(3):205-213. PubMed ID: 34878420
[TBL] [Abstract][Full Text] [Related]
18. The determinants of very severe immune-related adverse events associated with immune checkpoint inhibitors: A prospective study of the French REISAMIC registry.
Ruste V; Goldschmidt V; Laparra A; Messayke S; Danlos FX; Romano-Martin P; Champiat S; Voisin AL; Baldini C; Massard C; Laghouati S; Marabelle A; Lambotte O; Michot JM
Eur J Cancer; 2021 Nov; 158():217-224. PubMed ID: 34627664
[TBL] [Abstract][Full Text] [Related]
19. Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-mediated cardiovascular, rheumatic, and renal toxicities from checkpoint inhibitors.
Suarez-Almazor ME; Pundole X; Abdel-Wahab N; Johnson DB; Gupta D; Glezerman I; Cooksley T; Anderson R; Blidner A; Choi J; Dougan M; Ginex P; Girotra M; Shannon VR; Rapoport BL
Support Care Cancer; 2020 Dec; 28(12):6159-6173. PubMed ID: 32856212
[TBL] [Abstract][Full Text] [Related]
20. Management of Immunotherapy-Related Toxicities, Version 1.2019.
Thompson JA; Schneider BJ; Brahmer J; Andrews S; Armand P; Bhatia S; Budde LE; Costa L; Davies M; Dunnington D; Ernstoff MS; Frigault M; Hoffner B; Hoimes CJ; Lacouture M; Locke F; Lunning M; Mohindra NA; Naidoo J; Olszanski AJ; Oluwole O; Patel SP; Reddy S; Ryder M; Santomasso B; Shofer S; Sosman JA; Wahidi M; Wang Y; Johnson-Chilla A; Scavone JL
J Natl Compr Canc Netw; 2019 Mar; 17(3):255-289. PubMed ID: 30865922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
